Skip to main content
Figure 1 | BMC Health Services Research

Figure 1

From: Support for a tax increase to provide unrestricted access to an Alzheimer's disease medication: a survey of the general public in Canada

Figure 1

Support for an increase in annual personal income tax to fund a program of unrestricted access to Alzheimer's disease medications -- specific scenarios. Proportion of participants in favour of support for an increase did not differ by order of randomization: Symptom treatment, no adverse effects: = 29.62, p = 0.16. Symptom treatment, 30% chance of adverse effects: = 23.07, p = 0.42. Disease modification, no adverse effects: = 22.15, p = 0.51. Disease modification, 30% chance of adverse effects: = 32.67, p = 0.09.

Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us